Info Obat dan Regulator Obat Dunia

F
Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Sinus, and Restore Sinus Spray Products Due to Microbial Contamination
Replies
0
Views
248
FDA
F
F
FDA Roundup: October 6, 2023
Replies
0
Views
246
FDA
F
F
Risk of Invasive Disease in Preterm Infants Given Probiotics Formulated to Contain Live Bacteria or Yeast
Replies
0
Views
288
FDA
F
F
Stimulant Use Disorders: Developing Drugs for Treatment
Replies
0
Views
236
FDA
F
F
Remarks by Commissioner Califf at the Reagan Udall Foundation's Public Meeting on Strategies for Improving Public Understanding of FDA-Regulated Produ
Replies
0
Views
304
FDA
F
F
The Bad Ad Program
Replies
0
Views
327
FDA
F
F
Drug Trials Snapshot: LIVMARLI
Replies
0
Views
237
FDA
F
F
Initiatives at CDER
Replies
0
Views
274
FDA
F
F
FDA Launches Pilot Program to Help Further Accelerate Development of Rare Disease Therapies
Replies
0
Views
249
FDA
F
F
Drug Trials Snapshot: BYLVAY
Replies
0
Views
255
FDA
F
F
FDA Roundup: October 3, 2023
Replies
0
Views
267
FDA
F
F
Remarks by Commissioner Robert M. Califf to the 2024 Global Summit in Regulatory Science - 09/26/2023
Replies
0
Views
259
FDA
F
F
Common Issues with SEND Data Submitted for Safety Pharmacology Studies - 11/16/2023
Replies
0
Views
253
FDA
F
F
CPG Sec 100.200 FDA Jurisdiction Over Products Composed of Interstate Ingredients
Replies
0
Views
223
FDA
F
F
Remarks by Commissioner Califf to the Advancing Generic Drug Development: Translating Science to Approval Workshop - 09/13/2023
Replies
0
Views
274
FDA
F
F
KVK-Tech, Inc. Issues Voluntary Nationwide Recall of One Lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a Precautionary Measure Due to
Replies
0
Views
218
FDA
F
F
Speech by Commissioner Robert M. Califf to the House of Medicine - 06/16/2023
Replies
0
Views
235
FDA
F
F
April - June 2023 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
Replies
0
Views
316
FDA
F
F
Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamin
Replies
0
Views
217
FDA
F
E
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023, PRAC, 29/09/2023
Replies
0
Views
282
EMA
E
You must log in or register to post here.
Top